Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 3/20 | 0.48 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.48 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.48 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.48 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.48 |
| ▸ | BRAF | P15056 | 13/20 | 0.45 |
| ▸ | RAF1 | P04049 | 12/20 | 0.45 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.42 |
| ▸ | NAMPT | P43490 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CSF1R | P07333 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4541481 | 0.90 | RAB9A (0.47) | MAPK14MAPK13HSPB1MAPK12MAPK11 | |
| SCHEMBL4410942 | 0.89 | BRAF (0.45) | BRAFRAF1CSF1R | |
| SCHEMBL5604230 | 0.88 | RAF1 (0.59) | BRAFRAF1CSF1R | |
| SCHEMBL4411016 | 0.86 | BRAF (0.46) | MAPK14MAPK13HSPB1MAPK12MAPK11 | |
| SCHEMBL4412693 | 0.86 | RAF1 (0.49) | BRAFRAF1CSF1R | |
| SCHEMBL4565287 | 0.85 | RAB9A (0.47) | MAPK14HSPB1BRAFRAF1NAMPT | |
| SCHEMBL4566569 | 0.84 | RAF1 (0.55) | MAPK14MAPK13HSPB1MAPK12MAPK11 | |
| SCHEMBL4412542 | 0.83 | RAF1 (0.54) | MAPK14MAPK13HSPB1MAPK12MAPK11 | |
| SCHEMBL4408316 | 0.83 | MAPK14 (0.49) | MAPK14BRAFRAF1NAMPT | |
| SCHEMBL4407770 | 0.83 | MAPK14 (0.51) | MAPK14BRAFRAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2035005-A2 | THERAPY USING CYTOKINE INHIBITORS | Kemia, INC. (US) | 2009-03-18 | — | — | EP | disclosed |
| WO-2007146712-A2 | THERAPY USING CYTOKINE INHIBITORS | KEMIA, INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| WO-2007075896-A2 | HETEROCYCLIC CYTOKINE INHIBITORS | KEMIA, INC. (US) | 2007-07-05 | — | — | WO | disclosed |